Frankenius Equity AB, Ten Percent Owner at TriSalus Life Sciences, holds 6.23M shares in TriSalus Life Sciences (Ticker: TLSI). Most recently, Frankenius Equity AB Bought $62,972 shares of TriSalus Life Sciences on Dec 19, 2024 for an estimated value of 250.00K.
What is the percentage of profitable transactions made by Frankenius Equity AB?
The percentage of profitable transactions made by Frankenius Equity AB is ―.
What is the average return per transaction made by Frankenius Equity AB?
The average return per transaction made by Frankenius Equity AB is ―.
What stocks does Frankenius Equity AB hold?
Frankenius Equity AB holds: TLSI stocks.
What was Frankenius Equity AB’s latest transaction?
Frankenius Equity AB latest transaction was an Informative Buy of $250.00K.
What was Frankenius Equity AB's most profitable transaction?
Frankenius Equity AB’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Frankenius Equity AB's role in TriSalus Life Sciences?
Frankenius Equity AB's role in TriSalus Life Sciences is Ten Percent Owner.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.